Search Results for: HCV

December 9, 2014December 9, 2014

Antiretroviral Therapy May Offer Optimal Choice For Treating AIDS and Hepatitis C Simultaneously

Hepatitis C, News

In a new study entitled “Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients,” a team of researchers developed a dynamic mathematical model to determine how HIV ... Read more

December 8, 2014December 9, 2014

Ethiopian Study Offers Insights Into Hepatitis B and C Viruses in HIV Infected Children

Hepatitis B, Hepatitis C, News

A recent study entitled “ Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the felgehiwot referral hospital, Ethiopia” reports that HIV positive children ... Read more

December 1, 2014December 1, 2014

EMA Recommends Exviera & Viekirax To Treat Chronic Hepatitis C Virus Infections

Hepatitis C, News

The European Medicines Agency (EMA) recommended marketing authorization for Exviera (dasabuvir) and Viekirax (ombitasvir + paritaprevir + ritonavir) combined with other therapies and products to treat chronic hepatitis C virus (HCV) infections. Both ... Read more

November 25, 2014November 25, 2014

AbbVie’s Chronic Hepatitis C Combo Gains Positive Opinions From CHMP

Hepatitis C, News

AbbVie’s experimental Hepatitis C oral treatment consisting of the combination of VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) with EXVIERA™ (dasabuvir) with or without ribavirin (RBV), interferon-free, for patients with genotype 1 (GT1) and genotype 4 (GT4) chronic ... Read more

November 21, 2014November 21, 2014

First Oral Combination Drug for Hep C Approved in Europe

Hepatitis C, News

Gilead Sciences, Inc. recently announced that the European Commission has finally granted marketing authorization for their novel hepatitis C treatment Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), which is the first and only once-a-day ... Read more

November 19, 2014November 19, 2014

New Study Reveals Insights Into Hepatitis C Antiviral Resistance

Hepatitis C, News

A novel study on how miR-122 inhibition influences HCV replication, entitled “Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors,” was recently published in Nature Communications by Benjamin ... Read more

November 13, 2014November 14, 2014

Montefiore Medical Center Awarded With $3.5 Million Grant To Fight Hepatitis C

News

A $3.5 million grant was awarded to the Montefiore Medical Center to identify, diagnose and treat patients with hepatitis C (HCV). The grant is part of a $10 million Health Care Innovation Award ... Read more

November 13, 2014November 13, 2014

Phase 2 Study of Chronic Hepatitis C Treatment By Merck Shows Promise

Hepatitis C, News

Data from the C-WORTHY study evaluating the efficacy of treatment with Grazoprevir/Elbasvir of Chronic Hepatitis C in genotype 1 infected treatment-naïve and non-responders to peg-interferon/ribavirin (RP) patients was announced by ... Read more

November 12, 2014November 12, 2014

What Is the Real Cost of Treating All Patients with Hepatitis C And Can America Afford It?

Hepatitis C, News

Researchers from The University of Texas MD Anderson Cancer Center in Houston reported at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) their attempt to estimate ... Read more

November 10, 2014November 10, 2014

New York City Increases Hepatitis C Testing To Combat High Disease Incidences

Hepatitis C, News

Hepatitis C virus (HCV) is the leading cause of chronic liver disease and cirrhosis in the United States. According to the CDC, approximately 1.3% of the U.S. population is HCV ... Read more